glp 1 bone density The effects of GIP, GLP-1 and GLP-2 on markers of turnover: a review of the gut–bone axis Study reveals exercise and GLP-1

The degree of systolic blood pressure (SBP) reduction varies across studies

For years, glucagon-like peptide-1 receptor agonists were only available as injectables such as semaglutide and dulaglutide

Some patients achieve treatment goals at lower doses and remain on reduced maintenance protocols

These are compounded medications and are not FDA-approved

They are used primarily for weight management and the treatment of type 2 diabetes

Compounding pharmacies operate under state and federal compounding regulations, but their finished compounded products are not individually reviewed by the FDA for safety, effectiveness, or quality